19.12.2024 – 11:43Gesundheit / MedizinRHEACELL GmbH und Co. KGRHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcersmehr
24.09.2024 – 12:25WirtschaftRHEACELL GmbH und Co. KGRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVUmehr
17.06.2024 – 10:00WirtschaftAnker Innovations. LtdAnker SOLIX at Intersolar 2024: Premiere for energy storage system Anker SOLIX X1 and Anker SOLIX Solarbank 2mehr
